XENE FY 2017 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$311,000-82.8% YoY

Gross Profit

-$25M-8122.8% margin

Operating Income

-$33M-10474.3% margin

Net Income

-$31M-9872.7% margin

EPS (Diluted)

$-1.71

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$46M

Total Liabilities

$10M

Stockholders' Equity

$36M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$311,000	$2M	-82.8%
Gross Profit	-$25M	$689,000	-3766.5%
Operating Income	-$33M	-$25M	-31.3%
Net Income	-$31M	-$23M	-33.5%